Skip to content
Explore articles on technology trends, business strategies,…

Zimbabwe Rejects ‘Unbalanced’ US Health Aid Package Due to Information Apprehensions

Health funding image
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a major US health deal valued at $367m (£272m) over five years over Washington's demand for sensitive information.

The decision was revealed following a government memo from December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".

An official spokesperson later clarified that the United States was seeking biological samples for scientific study and commercial gain while refused to guarantee the resulting advantages from future medical innovations.

"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged continued talks to reach a agreement suitable to all parties so the nation's critical HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision follows a similar situation in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the security of citizens' health data.

Since returning to office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to boost openness and responsibility.

As per statements, Sixteen nations in Africa have to date signed similar agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this cooperation could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," the Ambassador added.

However, official spokesman Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to provide its genetic material and health information indefinitely, without any equivalent promise of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.

"In essence, our nation would provide the basic resources for medical research with no certainty that the end products would be accessible to our people if a new disease outbreak arise."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining systems already set up via the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.

"This mechanism is intended to guarantee that when a nation contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage ongoing dialogue with our American counterparts on how future co-operation could be arranged in a manner that respects the independence and interests of both nations."

Medical Community Reaction

A leading public health body said it acknowledged the official position, but suggested that talks should continue given that much of the country's HIV programmes were funded by foreign aid.

"In cases where technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.

This impasse emphasises the continuing debate between receiving vital international aid and safeguarding a country's data in an increasingly interconnected world.

By

Keith Harvey

A tech enthusiast and business strategist with over a decade of experience in digital transformation and startup consulting.

Tankevinkeln

Type to search articles.